Abstract
Background
Early risk stratification of acute pancreatitis is crucial to improve clinical outcomes. The objective of this study was to evaluate the ability of pancreatic stone protein (PSP) to predict acute pancreatitis severity and to compare it with the biomarkers and severity scores currently used for that purpose.
Patients and Methods
Prospective single-center observational study enrolling 268 adult patients with acute pancreatitis. Biomarkers including PSP were measured upon admission to the Emergency Department and severity scores as SOFA, PANC-3, and BISAP were computed. Patients were classified into mild-moderate (non-severe) and severe acute pancreatitis according to the Determinant-Based Classification Criteria. Area under the curve (AUC) and regression analysis were used to analyze the discrimination abilities and the association of biomarkers and scores with severity.
Results
Two hundred and thirty-five patients (87.7%) were classified as non-severe and 33 (12.3%) as severe acute pancreatitis. Median [IQR] PSP was increased in patients with severe acute pancreatitis (890 μg/L [559–1142] vs. 279 μg/L [141–496]; p < 0.001) and it was the best predictor (ROC AUC: 0.827). In multivariate analysis, PSP and urea were the only independent predictors for severe acute pancreatitis and a model combining them both (“biomarker model”) showed an AUC of 0.841 for prediction of severe acute pancreatitis, higher than the other severity scores.
Conclusions
PSP is a promising biomarker for predicting the severity of acute pancreatitis upon admission. A model combining PSP and urea might further constitute a potential tool for early risk stratification of this disease.
Similar content being viewed by others
Abbreviations
- APACHE:
-
Acute Physiology and Chronic Health Evaluation
- AUC:
-
Area under the curve
- BISAP:
-
Bedside Index for Severity in Acute Pancreatitis
- CBC:
-
Cell blood count
- CRP:
-
C-reactive protein
- DBC:
-
Determinant-Based Classification
- ED:
-
Emergency Department
- ICU:
-
Intensive Care Unit
- PSP:
-
Pancreatic stone protein
- ERCP:
-
Post-endoscopic retrograde cholangiopancreatography pancreatitis
- SOFA:
-
Sequential organ failure assessment
- ROC:
-
Receiver operating characteristic
References
Méndez-Bailón M, De Miguel Yanes JM, Jiménez García R, Hernández-Barrera V, Pérez-Farinós N, Lopez-de-Andrés A. National trends in incidence and outcomes of acute pancreatitis among type 2 diabetics and non-diabetics in Spain (2001–2011). Pancreatology. 2019;15:64–70.
Lankisch PG, Apte M, Banks PA. Acute pancreatitis. Lancet. 2015;386:85–96.
Hines OJ, Pandol SJ. Management of severe acute pancreatitis. BMJ. 2019;367:I6227.
Silva-Caz P, Abrantes AM, Castelo-Branco M, Gouveia A, Botelho MF, Tralhao JG. Multifactorial scores and biomarkers of prognosis of acute pancreatitis: Applications to research and practice. Int J Mol Sci. 2020;21:338.
Leppaniemi A, Tolonen M, Tarasconi A et al. 2019 WSES guidelines for the management of severe acute pancreatitis. World J Emerg Surg. 2019;14:27.
Miko A, Vigh E, Matrai P, Soos A, Garami A, Balasko M. Computed Tomography Severity Index vs. other Indices in the prediction of severity and mortality in acute pancreatitis: A predictive accuracy meta-analysis. Front Physiol. 2019;10:1002.
Forsmark CE, Vege SS, Wilcox CM. Acute pancreatitis. N Engl J Med.. 2017;376:598–599.
Valverde-López F, Wilcox CM, Redondo-Cerezo E. Evaluation and management of acute pancreatitis in Spain. Gastroenterol Hepatol. 2018;41:618–628.
Prazak J, Irincheeva I, Llewelyn MJ et al. Accuracy of pancreatic stone protein for the diagnosis of infection in hospitalized adults: a systematic review and individual patient level meta-analysis. Crit Care. 2021;25:182.
de Guadiana Romualdo LG, Albaladejo-Otón MD, Berger M et al. Prognostic performance of pancreatic stone protein in critically ill patients with sepsis. Biomarker Med. 2019;13:1469–1480.
Reding T, Palmiere C, Pazhepurackel C et al. The pancreas responds to remote damage and systemic stress by secretion of the pancreatic secretory proteins PSP/regI and PAP/regIII. Oncotarget. 2017;8:30162–30174.
Nakae Y, Naruse S, Kitagawa M et al. Molecular forms of serum pancreatic stone protein in acute pancreatitis. Int J Pancreatol. 1999;25:17–21.
Maraví Poma E, Zubia Olascoaga F, Petrov MS et al. Recommendations for intensive care management of acute pancreatitis. Med Intensiva. 2012;2013:163–179.
Bruno MJ, Dellinger EP, Forsmark CE et al. Determinant-based classification of acute pancreatitis severity: An international multidisciplinary consultation. Ann Surg. 2012;256:875–880.
Kolber W, Kuśnierz-Cabala B, Dumnicka P et al. Serum urokinase-type plasminogen activator receptor does not outperform C-reactive protein and procalcitonin as an early marker of severity of acute pancreatitis. J Clin Med. 2018;7:305.
Gurusamy KS, Debray TPA, Rompianesi G. Prognostic models for predicting the severity and mortality in people with acute pancreatitis. Cochrane Database Syst Rev. 2018;2018:CD013026.
Valverde-López F, Matas-Cobos AM, Alegría-Motte C, Jiménez-Rosales R, Úbeda-Muñoz M, Redondo-Cerezo E. BISAP, RANSON, lactate and other biomarkers in prediction of severe acute pancreatitis in an European cohort. J Gastroenterol Hepatol. 2017;32:1649–1656.
De-Madaria E, Molero X, Bonjoch L et al. Oleic acid chlorohydrin, a new early biomarker for the prediction of acute pancreatitis severity in humans. Ann Intensive Care. 2018;8:1.
Sternby H, Bolado F, Canaval-Zuleta HJ et al. Determinants of severity in acute pancreatitis: a nation-wide multicenter prospective cohort study. Ann Surg. 2019;270:348–355.
Staubli SM, Oertli D, Nebiker CA. Laboratory markers predicting severity of acute pancreatitis. Crit Rev Clin Lab Sci. 2015;52:273–283.
Mayer JM, Raraty M, Slavin J et al. Serum amyloid A is a better early predictor of severity than C-reactive protein in acute pancreatitis. Br J Surg. 2002;89:163–171.
Liang Y, Zhao X, Meng F. Procalcitonin, C-reactive protein, and neutrophil ratio contribute to the diagnosis and prognosis of severe acute pancreatitis. Iran J Public Health. 2019;48:2177–2186.
van den Berg FF, de Bruijn AC, van Santvoort HC, Issa Y, Boermeester MA. Early laboratory biomarkers for severity in acute pancreatitis. A systematic review and meta-analysis. Pancreatology. 2020;20:1302–1311.
Siriwardena AK, Jegatheeswaran S, Mason JM et al. PROCalcitonin-based algorithm for antibiotic use in Acute Pancreatitis (PROCAP): Study protocol for a randomised controlled trial. Trials. 2019;20:463.
Hagjer S, Kumar N. Evaluation of the BISAP scoring system in prognostication of acute pancreatitis: A prospective observational study. Int J Surg. 2018;54:76–81.
Zhou H, Mei X, He X, Lan T, Guo S. Severity stratification and prognostic prediction of patients with acute pancreatitis at early phase: A retrospective study. Medicine (Baltimore). 2019;98:e15275.
Choi JH, Kim MH, Cho DH et al. Revised Atlanta classification and determinant-based classification: Which one better at stratifying outcomes of patients with acute pancreatitis? Pancreatology. 2017;17:194–200.
Zhang YP, Liu C, Ye L et al. Early prediction of persistent organ failure by serum angiopoietin-2 in patients with acute pancreatitis. Dig Dis Sci. 2016;61:3584–3591. https://doi.org/10.1007/s10620-016-4323-y.
Shu W, Wan J, Yang X et al. Heparin-binding protein levels at admission and within 24 h are associated with persistent organ failure in acute pancreatitis. Dig Dis Sci. 2020. https://doi.org/10.1007/s10620-020-06660-1.
Eggimann P, Que YA, Rebeaud F. Measurement of pancreatic stone protein in the identification and management of sepsis. Biomark Med. 2019;13:135–145.
Funding
Abionic SA supported the study by providing reagents and other material for measurement of PSP. Abionic SA participates neither in the study design nor in the analysis or interpretation of the results.
Author information
Authors and Affiliations
Contributions
CRR and LGGR designed the study and analyzed the data. LGGR wrote the manuscript. SMS, JP, YAQ, and MDAO critically reviewed the manuscript. CRR and RB measured PSP levels in blood samples. SMS and VAS contributed to the enrollment of patients and clinical data collection. All authors approved the final version of the manuscript and its submission. All authors are responsible for the entire content of the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflict of interest.
Ethics approval
The study was approved by the Hospital Ethics Committee (E. O. 2018-51) and was carried out by following the Declaration of Helsinki of the World Medical Association.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Rodríguez Rojas, C., García de Guadiana-Romualdo, L., Morán Sánchez, S. et al. Role of Pancreatic Stone Protein as an Early Biomarker for Risk Stratification of Acute Pancreatitis. Dig Dis Sci 67, 3275–3283 (2022). https://doi.org/10.1007/s10620-021-07152-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-021-07152-6